Enabling eye screening for all

Enabling eye screening for all

Our mission is to help save the vision of millions of people.
On-the-spot detection of diabetic retinopathy

On-the-spot detection of diabetic retinopathy

Primary care physicians and their staff can now screen for and detect DR instantly.
We're a leader in handheld fundus cameras

We're a leader in handheld fundus cameras

We enable eye screening for everyone –
wherever they are.
previous arrow
next arrow

BREAKING NEWS

FDA clears Optomed Aurora AEYE handheld AI fundus camera for immediate on-the-spot detection of diabetic retinopathy. This system features groundbreaking diagnostic accuracy, >99% imageability, and using only one image per eye.

Learn more

Medical technology company Optomed is a leading manufacturer of handheld fundus cameras globally. By integrating our software solutions with our cameras, we enable eye screening for everyone – wherever they are.

Diabetic retinopathy

The number of people with diabetes has been growing rapidly around the world. One-third of them suffer from diabetic retinopathy, the most common cause of vision loss in working-age adults.

Diabetic retinopathy is treatable, if detected early. Due to the limited number of eye screening services, however, the majority of diabetics don’t have access to regular screenings.

50%+

of diabetics skip
annual eye exams

95%

of diabetics can reduce their risk of blindness
with early detection and treatment

38.4

million Americans
have diabetes

Our solution

Effective eye screening prevents diabetes-related blindness and reduces overall health care costs.

Our newest solution, Optomed Aurora AEYE, allows primary care physicians and their staff members to screen for and detect diabetic retinopathy instantly. The Optomed Aurora AEYE is the only FDA-cleared AI-enabled handheld fundus camera.

Explore more

Contact Us

    I have read Optomed's Privacy Statement and I accept the policy.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.